Publications by authors named "Clay Barbin"

Article Synopsis
  • - Clinical trials indicate that SGLT2 inhibitors provide significant benefits for patients with type 2 diabetes who also have cardiovascular and kidney issues, including reduced risks of major cardiovascular events and heart failure hospitalizations, and slowed kidney disease progression.
  • - The benefits of SGLT2 inhibitors seem to extend beyond just improving blood sugar levels and include lowering blood pressure and reducing body fat, while showing effects independent of renal function and other measures.
  • - However, these medications also carry risks for serious side effects like limb amputation and diabetic ketoacidosis due to their off-target effects on a sodium-proton exchanger which impacts pH recovery in tissues, explaining some complications like diabetic ulcers.
View Article and Find Full Text PDF
Article Synopsis
  • This review analyzes three major SGLT2 inhibitor trials (DECLARE-TIMI 58, CANVAS, and EMPA-REG OUTCOME) and their varied cardiovascular event results.
  • DECLARE-TIMI 58 had the lowest rates of adverse cardiac events and a higher average kidney function (eGFR), which may explain its different outcomes compared to the other trials.
  • The review suggests that future studies should standardize criteria for patient selection and endpoints to make fair comparisons among SGLT2 inhibitors.
View Article and Find Full Text PDF

Background: Fractional flow reserve(FFR) is a validated tool for evaluating functional severity and guiding the revascularization of angiographically moderate coronary artery lesions.

Objective: To study if there is a higher frequency of positive FFR measurements in the left anterior descending(LAD) versus other major coronary arteries and also evaluate the differences in the total length of the stent placed.

Methods: A retrospective cohort study including all subjects (January 2011 to December 2015) who had fractional flow reserve (FFR) measured during coronary catheterization was conducted.

View Article and Find Full Text PDF

In 2009, we described morphologic findings in 22 patients having resection of an ascending aortic aneurysm in the previous 11 years at the Baylor University Medical Center, and histologic examination of the aneurysmal wall disclosed classic findings of syphilitic aortitis. The major purpose of that extensively illustrated report was to describe the characteristic gross features of the aneurysm such that syphilitic aortitis might be better recognized at operation and appropriate antibiotics administered postoperatively. The aim of the present study was to emphasize that syphilis remains a major cause of ascending aortic aneurysm.

View Article and Find Full Text PDF

This report describes certain computed tomographic and morphologic features of syphilitic aortitis in 2 patients in whom the process involved the entire thoracic aorta.

View Article and Find Full Text PDF

Electrocardiographic voltage has been used to determine the presence of left ventricular hypertrophy for about 70 years. Varying electrocardiographic criteria have been applied. We have found total 12-lead QRS voltage to be most useful in this regard.

View Article and Find Full Text PDF

The MitraClip® has increasing use for severe, high surgical risk mitral regurgitation (MR). The MitraClip® is implanted percutaneously across the interatrial septum. Given the large diameter of the device delivery system, the femoral vein is the best option for central venous access.

View Article and Find Full Text PDF

A full-term male infant presented shortly after birth with respiratory distress. An echocardiogram done within the first hour of life showed an elevated pulmonary artery pressure, an associated right ventricular hypertrophy without a patent ductus arteriosus. The patient was treated for persistent pulmonary hypertension with favorable response.

View Article and Find Full Text PDF

Background: Cell therapy (CTh) is a promising novel therapy for myocardial infarction (MI) and ischemic cardiomyopathy (iCMP). Recognizing adverse events (AE) is important for safety evaluation, harm prevention and may aid in the design of future trials.

Objective: To define the prevalence of periprocedural AE in CTh trials in MI and iCMP.

View Article and Find Full Text PDF